Institute of Hygiene and Environmental Medicine, Charité UniversityMedicine, Berlin, Germany.
Infection. 2010 Feb;38(1):19-24. doi: 10.1007/s15010-009-9115-2. Epub 2009 Nov 10.
The aim of this study was to evaluate the impact of reducing the length of antibiotic prophylaxis for cerebro spinal shunts on total antibiotic use and key resistant pathogens.
In January 2004, the use of antibiotic prophylaxis was reduced to a single shot dose with cefuroxime in an intensive care unit (ICU). Prior to this intervention, prophylaxis with second-generation cephalosporins was administered during the entire period of external cerebro spinal fluid (CSF) drainage. The effect on the antibiotic use density (AD: DDD [defined daily doses] per 1,000 patient-days[pd]) was calculated prior to (January 2002-December 2003) and following implementation of the intervention(January 2004-December 2006) by segmented regression analysis of an interrupted time series. Resistance proportions(RP) and resistance densities (RD), defined as resistant pathogen/1,000 pd of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecalis or E. faecium, third-generation-resistant (3GC) Escherichia coli and Klebsiella pneumoniae, and imipenem-resistant Pseudomonus aeruginosa, were compared by the Fisher's exact test before and after the intervention.
Total antibiotic use by 147 DDD/1,000 pd decreased after the intervention when pre-operative prophylaxis was changed into single shot prophylaxis, from an estimated mean of 1,036 DDD/1,000 pd before the intervention to 887DDD/1,000 pd post-intervention. This decrease was primarily due to a significant reduction in the amount of cefuroxime used for prophylaxis. The reduction in total antibiotic consumption was sustainable, and it did not increase again during the next 36 months. The RR and RD of third-generation cephalosporin-resistant E. coli increased after January 2004, whereas the percentage of MRSA significantly decreased.
Change to single shot prophylaxis along with an ongoing antibiotic stewardship program resulted in a cut-back in total antibiotic use amounting to as much as 15%. It would therefore appear that targeting interventions aimed at reducing antibiotic prophylaxis in surgical ICUs may be very worthwhile.
本研究旨在评估减少脑脊髓分流术抗生素预防用药的长度对总抗生素使用和主要耐药病原体的影响。
2004 年 1 月,在重症监护病房(ICU)中,将抗生素预防用药减少至单次头孢呋辛剂量。在此干预之前,在整个外脑脊髓液(CSF)引流期间使用第二代头孢菌素进行预防。通过分段回归分析中断时间序列,计算干预实施前后(2002 年 1 月至 2003 年 12 月和 2004 年 1 月至 2006 年 12 月)抗生素使用密度(AD:每 1000 个患者日[pd]的 DDD [定义日剂量])的变化。通过 Fisher 确切检验比较干预前后耐甲氧西林金黄色葡萄球菌(MRSA)、万古霉素耐药粪肠球菌或屎肠球菌、第三代头孢菌素耐药(3GC)大肠埃希菌和肺炎克雷伯菌以及亚胺培南耐药铜绿假单胞菌的耐药比例(RP)和耐药密度(RD)。
术前预防改为单次预防后,147 DDD/1000 pd 的总抗生素使用量从干预前的估计平均值 1036 DDD/1000 pd 下降到干预后的 887 DDD/1000 pd。这种减少主要是由于预防用头孢呋辛用量显著减少。抗生素总消耗量的减少是可持续的,并且在接下来的 36 个月内没有再次增加。2004 年 1 月后,第三代头孢菌素耐药大肠埃希菌的 RR 和 RD 增加,而 MRSA 的百分比显著下降。
改为单次预防并结合持续的抗生素管理计划导致总抗生素使用量减少了多达 15%。因此,针对减少外科 ICU 中抗生素预防的靶向干预措施似乎非常值得。